Excellent news Idera Pharmaceuticals Reports Positive Data From Ongoing Phase 1/2 Clinical Trial of IMO-8400 in Patients With Waldenstrom’s Macroglobulinemia http://seekingalpha.com/pr/15564966-idera-pharmaceuticals-reports-positive-data-from-ongoing-phase-1-2-clinical-trial-of-imominus-8400-in-patients-with-waldenstrom-s-macroglobulinemia